Osteoporosis Animation: Sclerostin Inhibitor MOA

Created for Biopharmaceutical client
The project

This medical animation demonstrates the mechanism of action (MOA) of a novel bone forming agent that inhibits the protein sclerostin to promote gains in bone mass. We created an isolated bone cube and visually distinct cell groups to clearly illustrate the complementary processes of bone formation and bone resorption in osteoporosis and its treatment.

Created for
Biopharmaceutical client